Plain-English translation of NCT06635590 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how dangerously high potassium levels affect the heart in people with chronic kidney disease. The study uses two quick, painless heart tests—an electrocardiogram (ECG, which measures electrical activity) and an echocardiogram (ultrasound of the heart)—to see if certain heart changes can predict which patients are at higher risk of serious problems or death.
People with kidney disease often develop dangerously high potassium, which can cause sudden heart problems. Doctors need better ways to spot which patients are most at risk so they can treat them faster and more effectively.
You likely qualify if…
You likely don't qualify if…
You will come to the emergency department where doctors will take a blood sample to check your potassium level. Then you'll have two quick, non-invasive tests: an ECG (a simple chest sensor test) and an echocardiogram (a painless ultrasound of your heart). These same tests will be repeated after you receive treatment for high potassium. Doctors will then track your health outcomes at 24 hours, 7 days, and 30 days after your visit.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Turkey (Türkiye)
Enrollment target
~40 participants
Started
February 2024
Primary completion
February 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Gulsen AKCAY, Ass. Prof.
ass. prof. of organization
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.